Hello and thank you for posting,

Trials for the use of Tivdak for cervical cancer that has come back or has spread have been completed.

From the information I have found it is now waiting for approval to be licenced by the Medicines and Healthcare Regulatory Authority (MHRA) which is expected in July 2025. Once the drug is licenced it then needs to approved by other organisations for use in the NHS such as NICE.

Sometimes doctors can access drugs through the early access to medicines scheme (EAMS).

I hope this helps in some way. If you have any other questions or would like to talk to one of the nurses on the helpline, please feel free to get back to us. We are available between 9am and 5pm Monday to Friday and the freephone number to call is 0808 800 4040.

Take care,

Jemma